Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Insider Filings - COHEN FRED E
Last Updated 
20-Mar-17
Enter symbol:
symbol lookup

 

EDGAR Online: Get a Free Trial to EDGAR Online Premium | Full text Search

COHEN FRED E: Declared Holdings
Company/RelationshipReportedShares  Ownership
BioCryst Pharmaceuticals, Inc.
Director
NasdaqGS:BCRX
(historical quotes, profile, SEC, other insiders)
1-Mar-17117,469  Direct
CareDx, Inc.
Director
NasdaqGM:CDNA
(historical quotes, profile, other insiders)
1-Jan-1722,630  Direct
Five Prime Therapeutics, Inc.
Director
NasdaqGS:FPRX
(historical quotes, profile, other insiders)
11-Jan-1624,807  Direct
Genomic Health, Inc.
Director
NasdaqGS:GHDX
(historical quotes, profile, other insiders)
1-Jan-1765,578  Direct

Insider & restricted shareholder transactions reported over the last two years
DateSharesStockTransaction
1-Mar-17 1,602BCRX Acquisition (Non Open Market) at $6.24 per share.
(Value of $9,996)
1-Jan-17 340GHDX Acquisition (Non Open Market) at $29.39 per share.
(Value of $9,992)
1-Jan-17 3,391CDNA Acquisition (Non Open Market) at $0 per share.
1-Dec-16 1,788BCRX Acquisition (Non Open Market) at $5.59 per share.
(Value of $9,994)
1-Oct-16 2,643CDNA Acquisition (Non Open Market) at $0 per share.
1-Oct-16 345GHDX Acquisition (Non Open Market) at $28.92 per share.
(Value of $9,977)
1-Sep-16 2,433BCRX Acquisition (Non Open Market) at $4.11 per share.
(Value of $9,999)
15-Jul-16 5,000CDNA Acquisition (Non Open Market) at $0 per share.
1-Jul-16 373GHDX Acquisition (Non Open Market) at $26.74 - $26.74 per share.
(Value of about $9,974)
1-Jul-16 2,695CDNA Acquisition (Non Open Market) at $0 per share.
31-May-16 2,581BCRX Acquisition (Non Open Market) at $3.39 - $3.39 per share.
(Value of about $8,749)
1-Apr-16 1,954CDNA Acquisition (Non Open Market) at $0 per share.
1-Apr-16 392GHDX Acquisition (Non Open Market) at $25.48 - $25.48 per share.
(Value of about $9,988)
29-Feb-16 4,396BCRX Acquisition (Non Open Market) at $1.99 - $1.99 per share.
(Value of about $8,748)
11-Jan-16 24,695FPRX Option Exercise at $5.54 - $12.7 per share.
1-Jan-16 1,836CDNA Acquisition (Non Open Market) at $0 per share.
1-Jan-16 284GHDX Acquisition (Non Open Market) at $35.20 - $35.2 per share.
(Value of about $9,996)
30-Nov-15 824BCRX Acquisition (Non Open Market) at $10.61 - $10.61 per share.
(Value of about $8,742)
1-Oct-15 1,008CDNA Acquisition (Non Open Market) at $0 per share.
1-Oct-15 468GHDX Acquisition (Non Open Market) at $21.34 - $21.34 per share.
(Value of about $9,987)
31-Aug-15 751BCRX Acquisition (Non Open Market) at $11.64 - $11.64 per share.
(Value of about $8,741)
1-Jul-15 1,227CDNA Acquisition (Non Open Market) at $0 per share.
1-Jul-15 365GHDX Acquisition (Non Open Market) at $27.34 - $27.34 per share.
(Value of about $9,979)
29-May-15 780BCRX Acquisition (Non Open Market) at $11.21 - $11.21 per share.
(Value of about $8,743)
1-Apr-15 1,075CDNA Acquisition (Non Open Market) at $0 per share.
1-Apr-15 328GHDX Acquisition (Non Open Market) at $30.43 - $30.43 per share.
(Value of about $9,981)


EDGAR Online: Get a Free Trial to EDGAR Online Premium | Full text Search


Copyright © 2017 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Data and information are provided by EDGAR Online, Inc. for informational purposes only and not intended for trading purposes. Yahoo!, EDGAR Online, Inc. shall have no liability for the accuracy of the information furnished or for delays, omissions or opinions expressed therein. You may not use the information for any illegal purpose or furnish the information to any person, firm, or branch office for commercial re-use or re-sale.

Questions or Comments?